Meenakshi Sigireddi MD
Director of the High Risk Cancer Genetics Program at NYU Langone
Join to View Full Profile
145 E 32nd StFl 14New York, NY 10016
Phone+1 646-754-2205
Fax+1 646-754-2250
Dr. Sigireddi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mount Sinai Icahn School of MedicineClinical Genetics and Genomics, Fellowship, 2018 - 2020
Kaiser Permanente Northern California (Santa Clara)Residency, Internal Medicine, 2015 - 2018
Texas Tech University Health Sciences Center Paul L. Foster School of MedicineClass of 2015, MD
Certifications & Licensure
NY State Medical License 2020 - 2026
CA State Medical License 2017 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- Evaluation of the Stronger Together Peer Mentoring Model Among Patients With Breast and Gynecologic Cancer in Viet Nam.PhuongThao D Le, Carolyn Taylor, Mai T Do, Rachel Monahan, Sang Lee
JCO Global Oncology. 2024-11-01 - 2 citationsUptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial.Kimberly A Kaphingst, Wendy K Kohlmann, Rachelle Lorenz Chambers, Jemar R Bather, Melody S Goodman
JAMA Network Open. 2024-09-03 - Neuro-Ophthalmologic Variability in Presentation of Genetically Confirmed Wolfram Syndrome: A Case Series and Review.Ruben Jauregui, Nicolas J Abreu, Shani Golan, Joseph F Panarelli, Meenakshi Sigireddi
Brain Sciences. 2023-07-05
Press Mentions
Can Chatbots Help with Genetic Testing for Cancer Risk?September 10th, 2024
Grant Support
- Leveraging an electronic medical record infrastructure to identify primary care patients eligible for genetic testing for hereditary cancer and evaluate novel cancer genetics service delivery modelsUNIVERSITY OF UTAH2018–2025
- Leveraging an electronic medical record infrastructure to identify primary care patients eligible for genetic testing for hereditary cancer and evaluate novel cancer genetics service delivery modelsUNIVERSITY OF UTAH2018–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
